Engineered immune cells trial to fight colorectal cancer approved
Elix and Axcelead DDP to collaborate on targeted protein degrader discovery
Lotus Neuro launches to deliver therapies across blood-brain barrier
Antibody targeting TSLP achieves positive results in asthma study
RyboDyn joins Lilly Gateway Labs to advance next-gen immunotherapies
Study reveals processes important for skin cancer aggressiveness and identifies two classes of drugs that may block them
FDA Fast Track Designation for gel to treat calciphylaxis ulcers
Exobiosphere and Space Cargo Unlimited unite for high-throughput biotech in space
Saudi Arabia looks to global biotech collaboration
Targeting NK cells may mean more effective immunotherapy in resistant tumours
Base to Base biotech podcast 14: How to build reputation, and treating spastic paraplegia 47
Time to optimise novel cell-based mRNA therapeutics reduced by more than 90%